RESEARCH IMPACT - IBM€¦ · “By treating risk factors, you can actually get rid of this...

finding cures improving care

RESEARCHIMPACT

HOSPITALRESEARCH.COM.AU

USING YOUR IMMUNE SYSTEM TO BEAT BOWEL CANCER

HEART RESEARCH SAVING LIVES IN YOUR COMMUNITY

NEW AUDIOLOGY BOOTH CHANGING YOUNG LIVES

THRF Newsletter Edition 2 - Stakeholder Version.indd 1 5/07/2018 1:32:29 PM

Generating new knowledge of diseases that spark new ideas for the development of lifesaving treatments and cures. New research in the lab is aiming to understand the hormonal imbalance that occurs within breast cancer to lead to new treatments. Read more on page 7!Research has discovered a protein that can prevent salt-induced kidney disease. Read more on page 5!

Turning research ideas into new products and services to advance the prevention, diagnosis and treatment of diseases. A clinical trial has seen the introduction of a new lifesaving process for blood clot retrieval for stroke patients. Read more on page 10! Research at the Royal Adelaide Hospital is developing a new specialised, multidisciplinary clinic for patients living with Atrial Fibrillation. Read an update on page 4!

Influencing policy to bring about change that will benefit patients and their loved ones. Our Healthy Newborn Project is assessing the need for more antenatal ultrasound training in regional Australia. This will help inform future policy and save more lives. Read more on page 8! Our charitable affiliate, The Road Home, is conducting Post-Traumatic Stress research to help inform policies to improve the wellbeing of veterans, emergency service personnel and their families. Find out more at theroadhome.com.au.

Enabling new research through funding partnerships to speed up the discovery process. World-class research in the areas of diabetes, nutrition, obesity and gut health can now continue thanks to a new funding partnership between the University of Adelaide and THRF. Read about one of these projects on page 11!A new project will develop a universal therapy for both breast and prostate cancer thanks to funding from THRF in collaboration with other national organisations including the National Breast Cancer Foundation.

Developing research capacity to ensure the best people and resources can drive research forward and continue to save lives for years to come.

Our recent grant round in Adelaide’s north has armed a number of young researchers with funding to allow them to spend more time conducting their research. Stay tuned! In our next newsletter we will be announcing a number of new Fellowships at The Queen Elizabeth Hos-pital and Royal Adelaide Hospital. These bright young minds are the future of lifesaving medical research in South Australia!

MAKING A DIFFERENCEWHAT IS IMPACT IN MEDICAL RESEARCH? The Hospital Research Foundation (THRF) exists to save lives. We do this by funding medical research and patient care that will go on to make a difference in the lives of the community. A lifesaving difference!

There are so many ways that the medical research we support, thanks to our kind donors and ticket buyers in the Hospital Research Home Lottery, is making an impact.

OUR RESEARCH IS:

You can help make an even bigger impact! For every $1 you donate, we provide over $4 in grants to research and patient care. This is because our administration costs are covered by our commercial business activities (such as our lottery program), which also boosts our funds to research and patient care each year. You can feel proud knowing your donation makes an even bigger difference in your community.

2THRF Newsletter Edition 2 - Stakeholder Version.indd 2 5/07/2018 1:32:31 PM

MAKING A DIFFERENCE

We look forward to updating you on this lifesaving research in Adelaide's north as it progresses. Turn to page 11 to read about a world-class audiology booth now available at the Lyell McEwin Hospital thanks to the generous THRF community!

BREAKING THE CYCLE BETWEEN PREGNANCY COMPLICATIONS AND HEART DISEASE

Thanks to our generous donors and ticket buyers in the Hospital Research Home Lottery, THRF is proud to support research across all South Australian hospitals dedicated to saving lives.Now expanding our support to the Northern Adelaide Local Health Network, we recently directed over $733,000 to world-class research in Adelaide’s northern hospitals. These lifesaving funds were distributed to a range of vital areas of research and patient care important to our community including heart disease, pregnancy complications and palliative care. Here is a snapshot of two research projects now underway!

LIFESAVING RESEARCH IN OUR NORTHERN COMMUNITY

Professor Greg Crawford and his team will be leading a study to identify and promote 'Brilliant' palliative and end of life care at the Lyell McEwin Hospital. The study will address three important components for palliative care patients and their families – what does palliative care mean to them, what do they value most when being cared for in an acute hospital setting and how is brilliant palliative care enacted. The second aspect of the study will explore the use of a research technique to gain feedback and identify improvements for people who are receiving palliative care in northern Adelaide hospitals.

You can help make an even bigger impact! For ever $1 you donate, we provide over $4 in grants to research and patient care. This is because our administration costs are covered by our commercial business activities (such as our lottery program), which also boosts our funds to reserch and patient care each year.

Pictured right: Prof Crawford and colleagues Dr Aileen Collier, Ms Cathie Jeffs and Dr Lawrie Palmer (L-R) will ensure palliative care patients receive the best care possible.

Did you know that women who experience a pregnancy complication have an increased risk of developing premature heart disease before the age of 55?A first of its kind clinic has been developed at the Lyell McEwin Hospital that will evaluate and educate women with pregnancy complications, and identify women at high risk of heart disease.This clinic is informed by research led by Clinical Research Assistant Emily Aldridge, who now thanks to funding from THRF, will soon kick-start a three year PhD project. This project will ensure the clinic is informed by the latest research outcomes, measure how effective it is and determine what specific heart disease risks are most prevalent in mothers.

“Heart disease is the number one killer of Australian women, and pregnancy gives us a unique opportunity to identify those women who are at higher risk of developing premature heart disease,” Emily said.Pictured right: Emily's research will save the lives of young mums who develop premature heart disease.

ENSURING THE BEST PALLIATIVE CARE IN OUR NORTHERN HOSPITALS


How well do you know your own heart beat? What if it suddenly began to beat out of rhythm? This is the case for millions of people across the globe living with Atrial Fibrillation (AF), a condition affecting the heart, making it beat out of rhythm. This common condition not only affects a person’s heart, a third of all strokes also occur because of it. Thankfully, research supported by THRF at the Royal Adelaide Hospital is set to change this.Meet Professor Prashanthan (Prash) Sanders. An international authority in heart rhythm disorders, Prof Sanders is a clinician-scientist at the Royal Adelaide Hospital and University of Adelaide. His work has been responsible for the inclusion of risk factor management as a key component of managing AF in patients. Common risk factors for AF include high blood pressure, obesity, high cholesterol, sleep apnoea, physical inactivity and diabetes.“Our work has changed the three standard pillars of AF care to four: stroke prevention, heart rate control, rhythm control and now risk-factor treatment,” Prof Sanders said.“By treating risk factors, you can actually get rid of this condition.”Thanks to our generous donors, Prof Sanders and his team recently secured a grant from THRF to develop and implement a specialised and multi-disciplinary clinic at the Royal Adelaide Hospital that has an integrated care (i-CARE) approach for the management of AF. The i-CARE clinic will combine the important care components for AF and ensure collaboration between specialists, nurses and allied professionals all while maintaining a patient-centred approach to treatment.

A LIFE SAVED THANKS TO VITAL HEART RESEARCH

Prof Sanders and his team will save lives from a common heart condition.

Loving grandfather Barry's life was saved thanks to lifesaving heart research.

Prof Sanders' new clinic for Atrial Fibrillation sufferers will:

Combine the important care components for Atrial Fibrillation.

Ensure collaboration between all health professionals to provide the besttreatment for patients. This will save lives!

This clinic will be lifesaving for Barry, his brother and the thousands of other Australians living with this debilitating condition!

“We believe our clinic, enabled by this new grant, will reduce hospitalisation and mortality in patients with AF,” Prof Sanders said.This revolutionary clinic will change the lives of AF sufferers like Barry Prater. Barry was 63-years-old when he was struck down with AF, changing his life forever.

“When I was informed I had AF, I had no idea what it was. I felt terribly disappointed because I had always looked after myself,” Barry said.Following his shock diangosis, Barry had numerous visits to the emergency department and even suffered a mini-stroke. Thankfully after trying many treatments, he finally had a procedure that worked for him. With his brother also suffering from AF, Barry knows how crucial research like Prof Sanders and his teams is to combat this debilitating condition.

"This is a chronic condition and research is vital to develop strategies around prevention and effective treatments."


Adelaide researchers from the Centre for Cancer Biology have discovered for the first time a protein previously linked to controlling blood pressure also prevents salt-induced kidney disease. THRF is proud to support groundbreaking research at the Centre for Cancer Biology located in the University of South Australia's new Cancer Research Institute.

Leading this potentially life-changing research is Professor Sharad Kumar with Research Fellows Dr Jantina Manning and Dr Tanya Henshall who are hoping their discovery could lead to a new way of targeting kidney disease.

“We have identified a protein that protects the kidneys against salt-induced kidney damage. It does this by controlling the activity of a channel through which salt re-enters the blood stream following filtration by kidney,” Tanya explained.“We discovered that when this protein is not present there is a greater amount of this channel, which ultimately means more salt is entering into the body and this leads to kidney disease,” Jantina added. “If we block this channel with medication, we can in fact reduce the likelihood of kidney damage.” With high salt consumption common in our modern diet, and knowing this could give rise to kidney damage, Tanya and Jantina now want to better understand this protein and how it could help prevent kidney damage from occurring. “It may not be that a person is missing this protein, but rather has a mutation in it that means it’s not functioning properly. There is evidence that mutations in this protein relate to hypertension, and we now think that such mutations may also be contributing to kidney damage in some patients," Jantina said.

NEW PROTEIN COULD BE KEY TO BEATING KIDNEY DISEASE

"By targeting this protein and its downstream events, we could treat the kidney damage in these patients,” Jantina said. Currently 1 in 10 people are suffering from chronic kidney disease, with many unaware they are living with it. This discovery could improve outcomes for those diagnosed with the debilitating disease in the future.

“This discovery really opens up so many more avenues for further research in the fight for a cure for kidney disease,” Tanya said. “Whilst we are in the early stages of this work, there are options for treatments in the future, including looking at avenues of using drugs that are already out there,” Jantina said. “There is also the potential for the development of new medications in the future once we better understand the mechanisms involved,” Tanya added. With current kidney disease patients only having dialysis or a transplant available to them, this innovative research could open up a new treatment and ultimately save more lives from this debilitating disease. To find out more about research underway at the Centre for Cancer Biology visit hospitalresearch.com.au.

Adelaide researchers are one step closer to eliminating kidney disease.

WE SOLD OUT EARLY AGAIN! THANK YOU!

BECOME A MEMBER SO YOU NEVER MISS OUT!Visit www.homelottery.com.au


A LIFE-CHANGING RIDE FOR RURAL CANCER PATIENTS In March this year a group of 45 riders swapped their suits for lycra to take part in the annual Mercer SuperCycle, a 1000km ride over seven days raising life-changing funds for county cancer patients. The journey took the riders and support crew from Melbourne to Adelaide via the Great Ocean Road all in the name of raising funds for THRF’s Under Our Roof project.Thanks to the Mercer SuperCycle team and our kind donors, the Under Our Roof homes continue to provide a home away from home for country cancer patients and their families while in Adelaide for treatment. An amazing effort, the riders and crew raised over $345,000! These funds mean more much-needed homes can be built sooner for those who need it most. In June last year, Whyalla resident John Murray found himself in need of accommodation in Adelaide while receiving treatment for prostate cancer. It was during a regular check-up that John’s doctors discovered his Prostate-Specific Antigen (PSA) level was high. A biopsy soon confirmed news he didn’t want to hear.

“When I was first diagnosed I was shocked, I had just seen my father lose his life to prostate cancer and I was about to face the same battle,” John said. The treatment John opted for was brachytherapy, where radioactive seeds are injected into the prostate, damaging the cancer cells and destroying their ability to divide and grow. Having to undergo this operation in Adelaide, John and his wife Judy found comfort in THRF’s Under Our Roof homes.

“The Under Our Roof homes played a massive part in my treatment. It eased my stress when I had to stay in hospital for my operation knowing Judy was staying in the comfort of an Under Our Roof home,” John said.

“There was enough room in the home that I was able to have people come down and visit me which lifted my spirits immensely. Considering what was going on, it was lovely to have somewhere like Under Our Roof to stay during a difficult time.”Now cancer free, John and Judy are both grateful to have had a home away from home when they needed it most. If you would like to support or learn more about THRF's Under Our Roof project contact us on 08 8244 1100 or email [email protected].

Registrations are now open for Mercer SuperCycle 2019! The route will showcase some of the most picturesque regions of South Australia including the Fleurieu Peninsula, Clare and Barossa Wine Regions. This is a ride you won’t want to miss! To register or find out more visit supercycle.org.au.

John and his wife Judy found comfort in THRF's Under Our Roof homes.


INNOVATIVE TREATMENT TO BEAT BREAST CANCER

Dr Theresa Hickey from the Dame Roma Mitchell Cancer Research Laboratories at the University of Adelaide is pioneering vital research to better understand why patients develop therapy resistance in the hopes of crafting new treatment strategies to combat this fatal form of the disease.

“We believe that breast cancer represents a state of hormone imbalance and are exploring whether restoring this balance will be an effective, less toxic way of treating or preventing estrogen receptor positive breast cancer.” About 75 per cent of all breast cancers are estrogen receptor positive, meaning the cancer cells grow in response to the sex hormone estrogen. These cancers also commonly have other sex hormone receptors, including androgen and progesterone receptors. “Breast cancers that have all three sex hormone receptors are much more likely to respond to anti-estrogen therapy than those that have estrogen receptor alone. Those that have estrogen receptor and just one other sex hormone receptor lie in between these extremes in terms of therapy response,” Dr Hickey said.

“We know that the major cause of death from breast cancer is resistance to current estrogen receptor target therapies, so through our research we are developing alternative approaches to treat or prevent therapy resistant disease.”

Whilst estrogen receptor positive breast cancer has a targeted treatment, many patients develop resistance, leaving them with no option other than chemotherapy. Now these women have hope!

Women battling therapy resistant breast cancer may soon have a new treatment thanks to Dr Hickey.

Dr Hickey and Research Assistant Geri Laven-Law are determined to beat breast cancer.

To develop these alternative therapies, Dr Hickey and her team first had to understand the hormonal imbalance that occurs within breast cancer to decipher how to target this with a potential treatment. “The sex hormones estrogen and androgen are natural antagonists in men and women, and their relative action dictates biological gender and sex differences in the functioning of many body organs," she said. "The breast is an excellent example of sex hormone antagonism as breasts develop in women due to a predominance of estrogen action and do not develop in men due to a predominance of androgen action. “Since estrogen receptor positive breast cancer is driven by abnormal estrogen activity, we suspect the androgen receptor is not able to play its normal role to keep the balance in check.

“We aim, through a new therapy, to reawaken androgen receptor activity in estrogen receptor positive breast cancers to stimulate its ability to control the actions of estrogen and in turn prevent breast cancer from forming or treat it once it has developed.” Continuing to explore the role of these receptors in estrogen driven breast cancer, Dr Hickey’s research will open up avenues for repurposing drugs currently in use for other diseases in the hopes of beating the most aggressive breast cancers affecting our loved ones. You can help support research like this! Visit our website, hospitalresearch.com.au, to find out how.


THRF’s Healthy Newborn Project is well underway, dedicated to training healthcare professionals from across remote Australia in antenatal care to save the lives of mothers and babies in rural communities. Pioneering this project is Dr Nayana Parange, Professor Eva Bezak and their team from the University of South Australia, who in February and March this year held two workshops in Adelaide for doctors and midwives from across the country to learn how to conduct point of care ultrasound.

“An antenatal ultrasound can be lifesaving but at the moment not everyone is receiving at least one ultrasound during pregnancy – as health guidelines recommend - because of a lack of equipment and a lack of staff trained to use it,” Dr Parange said.

LIFESAVING SUPPORTFOR RURALMOTHERSAND BABIES

Doctors and midwives from rural and remote Australia came to Adelaide to train in point of care ultrasound.

Thanks to THRF's generous community, this is all about to change! Over 20 healthcare professionals travelled from all parts of rural and remote Australia including Clare, Barmera, Port Augusta and Nganampa in the Northern Territory to take part in the two workshops. Now equipped with their new skills these doctors and midwives have returned to their hometowns to help the many mothers in their community who are unable to access the most basic care for their unborn child. Dr Parange and her team have kick-started the next phase of the project where they will conduct a needs analysis survey to collate data around access to antenatal ultrasound scans in rural and remote communities across Australia. With an honours student now on board to support the project, the team are hopeful their findings could see policy development in this crucial area. This project will change the lives of so many mothers and their babies. Read below what the workshop participants had to say!

"The simulators were an excellent resource as it allowed me to practice without worrying about a real life patient as well as see many different scenarios. Thank you very much, I found it to be an informative and engaging workshop that will help my practice."

"Currently I’m the only midwife in my community. We are not a delivery site so women have to go to other towns to have their babies. This means they need to travel between 400 and 700km when they are around 37 weeks pregnant and stay in those communities to deliver their baby. This workshop was invaluable."

"Ultrasound is such a critical skill to have these days especially rural and remote. It's another one of those diagnostic aids that you need to have around you to help you manage someone who may be difficult to manage."


Dr Fenix's research will determine if your immune cells can help fight bowel cancer.

Leading this crucial research is Immunologist Dr Kevin Fenix from the Basil Hetzel Institute for Translational Health Research. Dr Fenix is investigating a group of immune cells that could be a key target to predict whether a patient’s bowel cancer is likely to spread. This discovery could save lives! “When bowel cancer is diagnosed early, patients have a 90 per cent cure rate with the treatments currently available to them,” Dr Fenix said.

"Recently, researchers have started to see these immune cells in cancer, in fact it has already been identified in breast cancer.“We are very lucky to have access to a bank that stores the tissue samples of patients who have had their cancer tumour removed through surgery. With these samples spanning a 20 year period, we’ve been able to track these patients over time and discovered those whose cancer sadly did end up returning had high levels of this immune cell. “Now we are trying to understand these cells more, how they interact and what role they play in helping cancer to spread through a person’s body.” To prove the crucial role these immune cells look to play in bowel cancer, the next step for Dr Fenix and his team is to begin collecting samples from patients who undergo surgery at the Royal Adelaide Hospital and The Queen Elizabeth Hospital. If their findings are positive, Dr Fenix is hopeful his research could lead to a new way of detecting and treating the heartbreaking disease. “After the patient has their surgery, we hope the clinicians will be able to test their tissue for these immune cells to determine how likely it is for their cancer to return and spread. Once we understand these cells more we’ll know if there is potential for a new treatment based on this finding.” Whilst in its early stages, this research could save the lives of so many diagnosed with bowel cancer in the future.

“It’s when the cancer reaches stage two and three that it becomes a problem. While the surgeon can remove the cancer, there is a 50 per cent chance of it returning and spreading to other areas of the patient’s body, most commonly the liver. It’s at this stage where patients sadly succumb to the disease.” Dr Fenix’s discovery could see clinicians be able to predict when a patient’s cancer is more likely to spread or return, meaning they can be more closely monitored.

“This immune cell I am studying is newly discovered, and is typically present in a person’s body when they have an infection," Dr Fenix said.

THE IMMUNE SYSTEM COULD HELP SAVE LIVES FROMBOWEL CANCER Lifesaving research is underway dedicated to preventing the heartbreak of bowel cancer. How? By understanding and potentially targeting our own immune cells!

Bowel cancer is the second most common cancer in men and women in Australia.

Your support will help stop this!

Did you know?


Did you know approximately one person has a stroke every 10 minutes in Australia? It’s the leading cause of death in our nation. Thankfully with new research developments, a cure could be closer than you think!

AT THE HEART OF CHANGE FOR STROKE PATIENTS

“I suffered a stroke while I was home alone as my husband Noel was in hospital receiving treatment for Stage 4 lung cancer. I was feeling a bit strange and by the time my daughter Tina phoned in the morning I realised I couldn’t speak properly,” Marilyn said. “I was rushed to hospital and doctors found I had a clot in my brain that could have resulted in severe disabilities or death. Fortunately, A/Prof Kleinig was on hand and I agreed to participate in his clinical trial. The trial drug thrombolysis was administered which successfully dissolved the clot.”Marilyn’s outcome was far better than her father’s, who experienced a debilitating stroke at the age of 62 in 1968, which severely affected his quality of life. “My father spent four months in hospital and had to learn to speak, walk and write again. I was in hospital three days and was only told I couldn’t drive for a month. I was able to resume life as normal.

“I feel extremely fortunate to be given such a lifesaving treatment and privileged to have had the opportunity to participate in the clinical trial. I thank A/Prof Kleinig, Ms Cranefield and the team at the Royal Adelaide Hospital Stroke Unit who saved my life.”Marilyn now supports lifesaving research through THRF that will help A/Prof Kleinig and Ms Cranefield continue making advancements and saving lives of those who suffer a stroke.

Would you like to find out more about how you can support research that will save the lives of people like Marilyn? Get in touch! Email [email protected] or call 08 8244 1100.

At the forefront of groundbreaking research outcomes in this area is Ms Jennifer Cranefield. She is the passionate Clinical Trials Coordinator for the Stroke Unit at the Royal Adelaide Hospital’s Clinical Trials Centre, proudly supported by THRF. Working alongside Roy Drew, who is also part of the Stroke Unit, Ms Cranefield manages all stroke clinical trials, giving hope to those who have been impacted by a stroke.“My day is filled with reviewing patients participating in the clinical trials, conducting clinical trial review visits within the research centre or within the community or rehabilitation setting, depending on patient needs,” Ms Cranefield said.Working in this role for four years now, Ms Cranefield has seen incredible results and improvements in stroke patient care. It’s the support of our community that means Ms Cranefield can help save the lives of people who suffer a debilitating stroke. People like Marilyn Jackson.Marilyn suffered a stroke earlier this year, but thankfully, she didn’t have any lasting side-effects thanks to Ms Cranefield and world-class researcher Associate Professor Tim Kleinig's clinical trial of a new stroke treatment.

Every day, Ms Cranefield is changing the lives of stroke sufferers.

Marilyn is living her best life thanks to revolutionary stroke research.


IMPROVING THE LIVES OF THE CRITICALLY ILL

Can you imagine ending up in an Intensive Care Unit (ICU) and when you are discharged your strength has deteriorated and your body is weaker than ever before?Around 130,000 Australians are admitted into ICU each year with many experiencing acute and rapid muscle loss as a result. A recent Translational Grant from THRF, is now supporting researchers at the Royal Adelaide Hospital, Professor Marianne Chapman, Dr Adam Deane and Dr Paul Young to change this outcome for Australians.Armed with $250,000 from THRF, the team will be kick-starting a randomised controlled trial to determine the ideal dose of protein patients may require to reduce muscle loss during critical illness in ICU and improve patients’ quality of life when returning home.“In the worst cases, it can take patients up to two years to return back to their previous level of fitness and function after an admission into ICU. This research is trying to stop that muscle and weight loss so patients can get back on their feet quicker,” Prof Chapman said.Higher protein doses can also improve other complications patients may experience as a result of an ICU admission. For example, a breathing machine can cause 20 per cent of patients to develop pneumonia after being in ICU.“We think keeping up the body’s condition with protein and nutrition can also strengthen people’s immune function to prevent infections, which will be another great outcome for patients in this trial,” Prof Chapman said.Prof Chapman and her team will be completing a preliminary study of approximately 120 patients from South Australian hospitals, gathering initial data needed for them to complete a national study of around 4000 patients. “Once we’ve got this data, we will then test different doses of protein safely and effectively for patients in ICU to determine the appropriate protein dose to provide patients that will reduce muscle loss.

WORLD-CLASSAUDIOLOGYBOOTH NOW OPENA new audiology booth is now open at the Lyell McEwin Hospital!THRF recently provided $90,000 for the purchase of a new world-class purpose built audiology booth for the Lyell McEwin Hospital for the first time! This groundbreaking booth will be located in the Outpatients Department and enable both adults and children to have their hearing assessed before and after surgery or treatment. The booth will be life-changing for four-year-old Lachlan McKeown and his mother Katherine who currently have to travel to Modbury Hospital every time Lachlan's eardrums unexplainably burst. “Having the new booth with all the latest technology nearby is going to be amazing,” Katherine said. “The problem we’ve had previously with Modbury is the technology there is so out of date. This booth and the equipment and technology going into it, is just phenomenal.”

“The grant from THRF has enabled us to get one step closer to improving the lives of those who end up in ICU.”THRF is so proud to support groundbreaking research like this, helping to change the lives of so many in our community. Prof Chapman is part of the University of Adelaide’s Centre of Research Excellence in Translating Nutritional Science to Good Health, which THRF also proudly supports.

Prof Chapman is leading vital research to improve outcomes for ICU patients.

The audiology booth will help young children like Lachlan and his loving mum. 11


finding cures improving care

60 WOODVILLE RD WOODVILLE, SOUTH AUSTRALIA, 5011PH: 08 8244 1100 FAX: 08 8244 1200HOSPITALRESEARCH.COM.AU

IN MEMORY GIFTSTHRF gratefully acknowledges donations in memory of:

DO YOU WANT TO REGULARLY SUPPORT LIFESAVING RESEARCH AND PATIENT CARE? VISIT HOSPITALRESEARCH.COM.AU OR CALL 08 8244 1100.

• Noah Al-Molliah

• Antonio Cannella

• Erskine Carter

• Maria Cutri

• Luisa D'Ambrosio

• Nicola de Ninis

• Kim Edwards

• Jane Gildea

• Bishop Goldsworthy

• Margaret Hansberry

• Panagiota Kaidonis

• Marika Kiroff

• Eleni Koutsoukos

• Doreen Lane

• William McBride

• Giuseppe Mercurio

• Triantafillo Moschovakis

• Paul Passaniti

• Giuseppina Petito

• Yvonne Rodda

• Robert Scott

• Salvatore Sepe

• Filomena Tripodi

• Primo Zambianco

• Franc Zeleznik

A GIFT FOR THE FUTURE

You can join Sylvia and leave a lasting gift to medical research through THRF.

A long time supporter of THRF and The Queen Elizabeth Hospital (TQEH), Sylvia Bridgman is proud to have left a gift in her Will to medical research that will save the lives of future generations.Sylvia’s decision stems from her long-lasting connection with TQEH, calling it a ‘home away from home’ for certain parts of her life. “If I had top medical cover and had been in the top private hospital, I still don’t believe I would have had the quality of treatment and care that I had at TQEH,” Sylvia said. This care is all informed by the very best research, that needs your support to continue for years to come.By leaving a gift in your Will, once your family are provided for, you will ensure that lifesaving medical research continues to benefit your family for generations to come.If you would like to learn more about leaving a gift in your Will, please contact our friendly team on 08 8244 1100.

LIFE-CHANGING BOOST FOR CANCER CENTRE Thanks to the generosity of local northern Commonwealth Bank branches, the Lyell McEwin Hospital’s Cancer Centre will receive $30,000 through THRF.This Centenary Grant was made possible thanks to the local Golden Grove, Salisbury and St Agnes Commonwealth Bank branches nominating the Lyell McEwin Hospital in recognition of the much-needed services it provides to the Northern Adelaide community.THRF is proud to help facilitate this life-changing donation thanks to our partnership with the Northern Adelaide Local Health Network.


RESEARCH IMPACT - IBM€¦ · “By treating risk factors, you can actually get rid of this...

Documents

Transcript of RESEARCH IMPACT - IBM€¦ · “By treating risk factors, you can actually get rid of this...